Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

The Shc protein Rai enhances T-cell survival under hypoxia.

Criscuoli M, Ulivieri C, Filippi I, Monaci S, Guerrini G, Crifò B, De Tommaso D, Pelicci G, Baldari CT, Taylor CT, Carraro F, Naldini A.

J Cell Physiol. 2020 Jan 15. doi: 10.1002/jcp.29461. [Epub ahead of print]

PMID:
31944299
2.

3-Amino-alkylated indoles: unexplored green products acting as anti-inflammatory agents.

Mazzotta S, Frattaruolo L, Brindisi M, Ulivieri C, Vanni F, Brizzi A, Carullo G, Cappello AR, Aiello F.

Future Med Chem. 2020 Jan;12(1):5-17. doi: 10.4155/fmc-2019-0234. Epub 2019 Nov 11.

PMID:
31710253
3.

A T Cell Suppressive Circuitry Mediated by CD39 and Regulated by ShcC/Rai Is Induced in Astrocytes by Encephalitogenic T Cells.

Ulivieri C, De Tommaso D, Finetti F, Ortensi B, Pelicci G, D'Elios MM, Ballerini C, Baldari CT.

Front Immunol. 2019 May 10;10:1041. doi: 10.3389/fimmu.2019.01041. eCollection 2019.

4.

p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape.

Patrussi L, Capitani N, Ulivieri C, Manganaro N, Granai M, Cattaneo F, Kabanova A, Mundo L, Gobessi S, Frezzato F, Visentin A, Finetti F, Pelicci PG, D'Elios MM, Trentin L, Semenzato G, Leoncini L, Efremov DG, Baldari CT.

Haematologica. 2019 Oct;104(10):2040-2052. doi: 10.3324/haematol.2018.209981. Epub 2019 Feb 28.

5.

Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents.

Brindisi M, Ulivieri C, Alfano G, Gemma S, de Asís Balaguer F, Khan T, Grillo A, Chemi G, Menchon G, Prota AE, Olieric N, Lucena-Agell D, Barasoain I, Diaz JF, Nebbioso A, Conte M, Lopresti L, Magnano S, Amet R, Kinsella P, Zisterer DM, Ibrahim O, O'Sullivan J, Morbidelli L, Spaccapelo R, Baldari C, Butini S, Novellino E, Campiani G, Altucci L, Steinmetz MO, Brogi S.

Eur J Med Chem. 2019 Jan 15;162:290-320. doi: 10.1016/j.ejmech.2018.11.004. Epub 2018 Nov 3.

PMID:
30448418
6.

Impact of erythrocyte species on assays for influenza serology.

Trombetta CM, Ulivieri C, Cox RJ, Remarque EJ, Centi C, Perini D, Piccini G, Rossi S, Marchi S, Montomoli E.

J Prev Med Hyg. 2018 Mar 30;59(1):E1-E7. doi: 10.15167/2421-4248/jpmh2018.59.1.870. eCollection 2018 Mar.

7.

Compartmentalized Cyclic AMP Production by the Bordetella pertussis and Bacillus anthracis Adenylate Cyclase Toxins Differentially Affects the Immune Synapse in T Lymphocytes.

Arumugham VB, Ulivieri C, Onnis A, Finetti F, Tonello F, Ladant D, Baldari CT.

Front Immunol. 2018 May 1;9:919. doi: 10.3389/fimmu.2018.00919. eCollection 2018.

8.

Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine.

Correale P, Botta C, Staropoli N, Nardone V, Pastina P, Ulivieri C, Gandolfo C, Baldari TC, Lazzi S, Ciliberto D, Giannicola R, Fioravanti A, Giordano A, Zappavigna S, Caraglia M, Tassone P, Pirtoli L, Cusi MG, Tagliaferri P.

Oncotarget. 2018 Apr 17;9(29):20539-20554. doi: 10.18632/oncotarget.24993. eCollection 2018 Apr 17.

9.
10.

Correction: The Adaptor Protein Rai/ShcC Promotes Astrocyte-Dependent Inflammation during Experimental Autoimmune Encephalomyelitis.

Ulivieri C, Savino MT, Luccarini I, Fanigliulo E, Aldinucci A, Bonechi E, Benagiano M, Ortensi B, Pelicci G, D'Elios MM, Ballerini C, Baldari CT.

J Immunol. 2016 Nov 15;197(10):4178. No abstract available.

11.

Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients.

Martino EC, Misso G, Pastina P, Costantini S, Vanni F, Gandolfo C, Botta C, Capone F, Lombardi A, Pirtoli L, Tassone P, Ulivieri C, Tagliaferri P, Cusi MG, Caraglia M, Correale P.

Cell Death Discov. 2016 Oct 3;2:16025. eCollection 2016.

12.

The Adaptor Protein Rai/ShcC Promotes Astrocyte-Dependent Inflammation during Experimental Autoimmune Encephalomyelitis.

Ulivieri C, Savino MT, Luccarini I, Fanigliulo E, Aldinucci A, Bonechi E, Benagiano M, Ortensi B, Pelicci G, D'Elios MM, Ballerini C, Baldari CT.

J Immunol. 2016 Jul 15;197(2):480-90. doi: 10.4049/jimmunol.1502063. Epub 2016 Jun 10. Erratum in: J Immunol. 2016 Nov 15;197(10 ):4178.

13.

Severe Reduction in Number and Function of Peripheral T Cells Does Not Afford Protection toward Emphysema and Bronchial Remodeling Induced in Mice by Cigarette Smoke.

De Cunto G, Lunghi B, Bartalesi B, Cavarra E, Fineschi S, Ulivieri C, Lungarella G, Lucattelli M.

Am J Pathol. 2016 Jul;186(7):1814-1824. doi: 10.1016/j.ajpath.2016.03.002. Epub 2016 May 6.

14.

Development of novel cyclic peptides as pro-apoptotic agents.

Brindisi M, Maramai S, Brogi S, Fanigliulo E, Butini S, Guarino E, Casagni A, Lamponi S, Bonechi C, Nathwani SM, Finetti F, Ragonese F, Arcidiacono P, Campiglia P, Valenti S, Novellino E, Spaccapelo R, Morbidelli L, Zisterer DM, Williams CD, Donati A, Baldari C, Campiani G, Ulivieri C, Gemma S.

Eur J Med Chem. 2016 Jul 19;117:301-20. doi: 10.1016/j.ejmech.2016.04.001. Epub 2016 Apr 5.

PMID:
27150036
15.

Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients.

Correale P, Botta C, Martino EC, Ulivieri C, Battaglia G, Carfagno T, Rossetti MG, Fioravanti A, Guidelli GM, Cheleschi S, Gandolfo C, Carbone F, Baldari TC, Tassone P, Tagliaferri P, Pirtoli L, Cusi MG.

Oncoimmunology. 2015 Dec 21;5(4):e1101205. eCollection 2016 Apr.

16.

Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: an in-vitro study in healthy humans.

Fanigliulo D, Lazzerini PE, Capecchi PL, Ulivieri C, Baldari CT, Laghi-Pasini F.

Int Immunopharmacol. 2015 Feb;24(2):276-284. doi: 10.1016/j.intimp.2014.12.021. Epub 2014 Dec 20.

PMID:
25536542
17.

GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells.

Livide G, Patriarchi T, Amenduni M, Amabile S, Yasui D, Calcagno E, Lo Rizzo C, De Falco G, Ulivieri C, Ariani F, Mari F, Mencarelli MA, Hell JW, Renieri A, Meloni I.

Eur J Hum Genet. 2015 Feb;23(2):195-201. doi: 10.1038/ejhg.2014.81. Epub 2014 Jun 11.

18.

Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signalling.

Shabani M, Bayat AA, Jeddi-Tehrani M, Rabbani H, Hojjat-Farsangi M, Ulivieri C, Amirghofran Z, Baldari CT, Shokri F.

Immunology. 2014 Nov;143(3):341-53. doi: 10.1111/imm.12311.

19.

The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma.

Ambrosio MR, Navari M, Di Lisio L, Leon EA, Onnis A, Gazaneo S, Mundo L, Ulivieri C, Gomez G, Lazzi S, Piris MA, Leoncini L, De Falco G.

Infect Agent Cancer. 2014 Apr 14;9:12. doi: 10.1186/1750-9378-9-12. eCollection 2014.

20.

The KSR2-calcineurin complex regulates STIM1-ORAI1 dynamics and store-operated calcium entry (SOCE).

Giurisato E, Gamberucci A, Ulivieri C, Marruganti S, Rossi E, Giacomello E, Randazzo D, Sorrentino V.

Mol Biol Cell. 2014 Jun;25(11):1769-81. doi: 10.1091/mbc.E13-05-0292. Epub 2014 Mar 26.

21.

Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.

Ulivieri C, Baldari CT.

Pharmacol Res. 2014 Oct;88:41-52. doi: 10.1016/j.phrs.2014.03.001. Epub 2014 Mar 21. Review.

PMID:
24657239
22.

p66Shc regulates vesicle-mediated secretion in mast cells by affecting F-actin dynamics.

Masi G, Mercati D, Vannuccini E, Paccagnini E, Riparbelli MG, Lupetti P, Pelicci PG, Baldari CT, Ulivieri C.

J Leukoc Biol. 2014 Feb;95(2):285-92. doi: 10.1189/jlb.0313178. Epub 2013 Sep 27.

PMID:
24078705
23.

T-cell-based immunotherapy of autoimmune diseases.

Ulivieri C, Baldari CT.

Expert Rev Vaccines. 2013 Mar;12(3):297-310. doi: 10.1586/erv.12.146. Review.

PMID:
23496669
24.

The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development.

Savino MT, Ulivieri C, Emmi G, Prisco D, De Falco G, Ortensi B, Beccastrini E, Emmi L, Pelicci G, D'Elios MM, Baldari CT.

J Leukoc Biol. 2013 Apr;93(4):549-59. doi: 10.1189/jlb.0712331. Epub 2013 Jan 23.

PMID:
23345394
25.

The Shc family protein adaptor, Rai, negatively regulates T cell antigen receptor signaling by inhibiting ZAP-70 recruitment and activation.

Ferro M, Savino MT, Ortensi B, Finetti F, Genovese L, Masi G, Ulivieri C, Benati D, Pelicci G, Baldari CT.

PLoS One. 2011;6(12):e29899. doi: 10.1371/journal.pone.0029899. Epub 2011 Dec 29.

26.

p66Shc is a negative regulator of FcεRI-dependent signaling in mast cells.

Ulivieri C, Fanigliulo D, Masi G, Savino MT, Gamberucci A, Pelicci PG, Baldari CT.

J Immunol. 2011 May 1;186(9):5095-106. doi: 10.4049/jimmunol.1001391. Epub 2011 Mar 23.

27.

Cell death: insights into the ultrastructure of mitochondria.

Ulivieri C.

Tissue Cell. 2010 Dec;42(6):339-47. doi: 10.1016/j.tice.2010.10.004. Epub 2010 Nov 2. Review.

PMID:
21047663
28.

Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus.

Benati D, Ferro M, Savino MT, Ulivieri C, Schiavo E, Nuccitelli A, Pasini FL, Baldari CT.

J Leukoc Biol. 2010 Mar;87(3):433-42. doi: 10.1189/jlb.0409273. Epub 2009 Nov 5.

PMID:
19892847
29.

Rai acts as a negative regulator of autoimmunity by inhibiting antigen receptor signaling and lymphocyte activation.

Savino MT, Ortensi B, Ferro M, Ulivieri C, Fanigliulo D, Paccagnini E, Lazzi S, Osti D, Pelicci G, Baldari CT.

J Immunol. 2009 Jan 1;182(1):301-8.

30.

Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation.

Ulivieri C, Fanigliulo D, Benati D, Pasini FL, Baldari CT.

Eur J Immunol. 2008 Oct;38(10):2832-44. doi: 10.1002/eji.200838278.

31.

Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.

Ulivieri C, Citro A, Ivaldi F, Mascolo D, Ghittoni R, Fanigliulo D, Manca F, Baldari CT, Li Pira G, Del Pozzo G.

Immunol Lett. 2008 Aug 15;119(1-2):62-70. doi: 10.1016/j.imlet.2008.04.004. Epub 2008 May 19.

PMID:
18538862
32.

The proapoptotic and antimitogenic protein p66SHC acts as a negative regulator of lymphocyte activation and autoimmunity.

Finetti F, Pellegrini M, Ulivieri C, Savino MT, Paccagnini E, Ginanneschi C, Lanfrancone L, Pelicci PG, Baldari CT.

Blood. 2008 May 15;111(10):5017-27. doi: 10.1182/blood-2007-12-130856. Epub 2008 Mar 11.

PMID:
18334675
33.
34.

p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells.

Patrussi L, Ulivieri C, Lucherini OM, Paccani SR, Gamberucci A, Lanfrancone L, Pelicci PG, Baldari CT.

Blood. 2007 Sep 15;110(6):1730-8. Epub 2007 May 30.

PMID:
17537990
35.

Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases.

Ghittoni R, Napolitani G, Benati D, Ulivieri C, Patrussi L, Laghi Pasini F, Lanzavecchia A, Baldari CT.

Eur J Immunol. 2006 Nov;36(11):2885-93. Erratum in: Eur J Immunol. 2006 Dec;36(12):3381. Uliveri, Cristina [corrected to Ulivieri, Cristina].

36.

Expression in T-cells of the proapoptotic protein p66SHC is controlled by promoter demethylation.

Pezzicoli A, Ulivieri C, Capitani N, Ventura A, Pelicci P, Baldari CT.

Biochem Biophys Res Commun. 2006 Oct 13;349(1):322-8. Epub 2006 Aug 17.

PMID:
16934220
37.

p66SHC promotes T cell apoptosis by inducing mitochondrial dysfunction and impaired Ca2+ homeostasis.

Pellegrini M, Finetti F, Petronilli V, Ulivieri C, Giusti F, Lupetti P, Giorgio M, Pelicci PG, Bernardi P, Baldari CT.

Cell Death Differ. 2007 Feb;14(2):338-47. Epub 2006 Jun 23.

38.

Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells.

Crotta S, Ronconi V, Ulivieri C, Baldari CT, Valiante NM, Abrignani S, Wack A.

Eur J Immunol. 2006 Apr;36(4):919-29. Erratum in: Eur J Immunol. 2006 May;36(5):1350. Valiente, Nicholas M [corrected to Valiante, Nicholas M].

39.

The BCR signalosome: where cell fate is decided.

Ulivieri C, Baldari CT.

J Biol Regul Homeost Agents. 2005 Jan-Jun;19(1-2):1-16. Review.

PMID:
16178270
40.

Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects.

Paccani SR, Boncristiano M, Patrussi L, Ulivieri C, Wack A, Valensin S, Hirst TR, Amedei A, Del Prete G, Telford JL, D'Elios MM, Baldari CT.

Blood. 2005 Jul 15;106(2):626-34. Epub 2005 Apr 7.

PMID:
15817684
41.

Nonsteroidal anti-inflammatory drugs inhibit a Fyn-dependent pathway coupled to Rac and stress kinase activation in TCR signaling.

Paccani SR, Patrussi L, Ulivieri C, Masferrer JL, D'Elios MM, Baldari CT.

Blood. 2005 Mar 1;105(5):2042-8. Epub 2004 Oct 28.

PMID:
15514010
42.

Inhibition of ShcA isoforms p46/p52Shc enhances HIV-1 replication in CD4+ T-lymphocytes.

Benetti L, Calistri A, Ulivieri C, Cabrelle A, Baldari CT, Palù G, Parolin C.

J Cell Physiol. 2004 Apr;199(1):40-6.

PMID:
14978733
43.

p66SHC promotes apoptosis and antagonizes mitogenic signaling in T cells.

Pacini S, Pellegrini M, Migliaccio E, Patrussi L, Ulivieri C, Ventura A, Carraro F, Naldini A, Lanfrancone L, Pelicci P, Baldari CT.

Mol Cell Biol. 2004 Feb;24(4):1747-57.

44.

The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms.

Boncristiano M, Paccani SR, Barone S, Ulivieri C, Patrussi L, Ilver D, Amedei A, D'Elios MM, Telford JL, Baldari CT.

J Exp Med. 2003 Dec 15;198(12):1887-97.

45.

T cell costimulation by the hepatitis C virus envelope protein E2 binding to CD81 is mediated by Lck.

Soldaini E, Wack A, D'Oro U, Nuti S, Ulivieri C, Baldari CT, Abrignani S.

Eur J Immunol. 2003 Feb;33(2):455-64.

46.

Normal B-1 cell development but defective BCR signaling in Lck-/- mice.

Ulivieri C, Valensin S, Majolini MB, Matthews RJ, Baldari CT.

Eur J Immunol. 2003 Feb;33(2):441-5.

47.

F-actin dynamics control segregation of the TCR signaling cascade to clustered lipid rafts.

Valensin S, Paccani SR, Ulivieri C, Mercati D, Pacini S, Patrussi L, Hirst T, Lupetti P, Baldari CT.

Eur J Immunol. 2002 Feb;32(2):435-46.

48.

Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction.

Paccani SR, Boncristiano M, Ulivieri C, D'Elios MM, Del Prete G, Baldari CT.

J Biol Chem. 2002 Jan 11;277(2):1509-13. Epub 2001 Nov 7.

49.

Defective signaling to Fyn by a T cell antigen receptor lacking the alpha -chain connecting peptide motif.

Ulivieri C, Peter A, Orsini E, Palmer E, Baldari CT.

J Biol Chem. 2001 Feb 2;276(5):3574-80. Epub 2000 Oct 31.

50.

Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects.

Boncristiano M, Majolini MB, D'Elios MM, Pacini S, Valensin S, Ulivieri C, Amedei A, Falini B, Del Prete G, Telford JL, Baldari CT.

Eur J Immunol. 2000 Sep;30(9):2632-8.

Supplemental Content

Loading ...
Support Center